Larimar Therapeutics, Inc. (LRMR) Financials
LRMR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 95.9 million | 14.2 million |
2023-09-30 | 104.0 million | 11.2 million |
2023-06-30 | 111.7 million | 11.8 million |
2023-03-31 | 118.9 million | 12.7 million |
LRMR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -9.5 million | 1.9 million |
2023-09-30 | -9.2 million | 1.8 million |
2023-06-30 | -7.4 million | 2.0 million |
2023-03-31 | -7.6 million | 1.8 million |
LRMR Net Income
No data available :(
LRMR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 86.8 million | - | 5.5 million |
2023-09-30 | 95.6 million | - | 5.4 million |
2023-06-30 | 104.2 million | - | 5.1 million |
2023-03-31 | 111.5 million | - | 5.2 million |
LRMR Shares Outstanding
LRMR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 164000 | 10.6 million | 3.5 million | - |
2023-09-30 | - | 6.6 million | 3.8 million | - |
2023-06-30 | - | 5.9 million | 3.7 million | - |
2023-03-31 | - | 4.6 million | 3.1 million | - |
LRMR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 81000 |
2023-09-30 | - | 69000 |
2023-06-30 | - | 49000 |
2023-03-31 | - | 54000 |
LRMR
Price: $6.44
52 week price:
Earnings Per Share: -0.84 USD
P/E Ratio: -10.25
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 194
Market Capitalization: 474.7 million